Weil, Cooley Guide $3.7B Sanofi, Principia Biopharma Deal
Sanofi, advised by Weil Gotshal & Manges LLP, said Monday it's buying Cooley-led Principia Biopharma in a deal worth $3.68 billion that the French buyer expects will boost its work developing treatments...To view the full article, register now.
Already a subscriber? Click here to view full article